Kiem Lab's Korashon Watts explores cord blood stem cell expansion; lauded by American Society of Gene & Cell Therapy
May 21, 2012
| By Colleen Steelquist
Dr. Korashon Watts of the Fred Hutchinson Cancer Research Center Clinical Research Division recently won an Excellence in Research award from the American Society of Gene & Cell Therapy. Her abstract, focused on cord blood stem cell expansion, was selected as one of the top six submitted by a postdoctoral fellow or student for the ASGCT annual meeting in Philadelphia earlier this month.
Hans-Peter Kiem study is first to show patients' own gene-modified blood stem cells can protect bone marrow from chemotherapy toxicity
May 14, 2012
| By Dean Forbes
For the first time, Fred Hutchinson Cancer Research Center scientists have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. Initial results of the ongoing, small clinical trial of three patients with glioblastoma showed that two patients survived longer than predicted if they had not been given the transplants, and a third patient remains alive with no disease progression almost three years after treatment.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.